The report "Interventional
Cardiology & Peripheral Vascular Devices Market (Angioplasty Balloon, Stent,
Catheters, EVAR Stent Grafts, Abdominal Aortic Aneurysm, IVC Filter, Plaque
Modification, Hemodynamic Flow Alteration, Accessories, Guidewire) - Forecasts
to 2021", The
global interventional cardiology and peripheral vascular devices market is
expected to reach USD 31.47 Billion by 2021 from USD 21.83 Billion in 2016, at
a CAGR of 7.1% from 2016 to 2021.
Rising aging
population, rising incidence of cardiovascular diseases, increasing demand of
minimally invasive procedures, and technological advancements are the major
factors driving the growth of this market.
On the basis of product, the
interventional cardiology market is segmented into angioplasty balloons,
angioplasty stents, catheters, EVAR stent grafts, IVC filters, plaque modification
devices, hemodynamic flow alteration devices, and accessories. The angioplasty
stents segment showcase high growth potential owing to technological
advancements, rising number of regulatory approvals, and increasing investments
by companies to develop new devices.
On the basis of type, the angioplasty
stents market is segmented into drug-eluting stents, bare-metal stents, and
bioabsorbable stents. The drug-eluting stents segment is projected to witness
the highest growth in this market due to increasing number of regulatory
approvals and new product launches.
On the basis of type, the catheters
market is segmented into IVUS/OCT, angiography catheters, and guiding
catheters. The IVUS/OCT segment is projected to witness the highest growth in
this market due to increasing penetration rates and rapid advancements &
innovations in these systems.
On the basis of type, the EVAR stent
grafts market is segmented into abdominal aortic aneurysms and thoracic aortic
aneurysms. The abdominal aortic aneurysms segment is projected to witness the
highest growth in this market due to rising incidence of smoking and
hypertension.
The Sample Report For This Report@
Geographically, the interventional
cardiology market is dominated by North America, followed by Europe, Asia, and
the Rest of the World (RoW). Growth in the North American region is primarily
driven by the rising incidence of cardiovascular diseases, rapidly growing
geriatric population, and technological advancements. However, the Asian market
is projected to grow at the highest CAGR during the forecast period.
Key players operating in the
interventional cardiology market include Abbott Laboratories (U.S.), Boston
Scientific Corporation (U.S.), B. Braun Melsungen AG (Germany), Cordis
Corporation (U.S.), C.R. Bard, Inc. (U.S.), Medtronic plc (U.S.), and Terumo
Corporation (Japan)
Get The PDF Brochure For This Report@
No comments:
Post a Comment